Inflammatory breast cancer as a model disease to study tumor angiogenesis: Results of a phase IB trial of combination SU54 16 and doxorubicin

Beth Overmoyer, Pingfu Fu, Charles Hoppel, Tomas Radivoyevitch, Robert Shenk, Marjie Persons, Paula Silverman, Kelly Robertson, Nicholas P. Ziats, Jay K. Wasman, Fadi W. Abdul-Karim, John A. Jesberger, Jeffrey Duerk, Paul Hartman, Shelli Hanks, Jonathan Lewin, Afshin Dowlati, Keith McCrae, Percy Ivy, Scot C. Remick

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'Inflammatory breast cancer as a model disease to study tumor angiogenesis: Results of a phase IB trial of combination SU54 16 and doxorubicin'. Together they form a unique fingerprint.

Medicine & Life Sciences